# Cochlear agrees to acquire Oticon Medical from Demant

Cochlear Limited agreed to acquire Oticon Medical, Demant's hearing implants business, for DKK 850 million (approx. AUD 170 million). The deal includes cochlear and acoustic implants and a base of over 75,000 recipients.

- Type: Acquisition
- Announced: 2022-04-27
- Where: Denmark
- Value: $120.0M (850.0M DKK)
- Status: announced
- Products: hearing implants, cochlear implants, acoustic implants
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Cochlear](https://endata.com/companies/1739.md) (acquirer)
- [Oticon Medical](https://endata.com/companies/62544.md) (target)
- [Demant](https://endata.com/companies/62545.md) (partner)

## Sources

- [cochlear.com](https://www.cochlear.com/au/en/corporate/media/media-releases/media-releases/2022/2022-04-27-cochlear-agrees-to-acquire-oticon-medical), 2022-04-27: "Cochlear Limited, a global leader in implantable hearing solutions, agrees to acquire Oticon Medical for DKK850 million"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.